Crossmark

Pharmacogenomics of etanercept, infliximab, adalimumab and methotrexate in rheumatoid arthritis. A structured review

Crossref DOI link: https://doi.org/10.1016/j.rcreue.2018.08.001

Published Print: 2018-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Puentes Osorio, Yolima

Amariles Muñoz, Pedro

Aristizábal Bernal, Beatriz Helena

Pinto Peñaranda, Luis Fernando

Calleja Hernández, Miguel Ángel
License Information

Text and Data Mining valid from 2018-01-01
More Information

This article is maintained by: Elsevier

Article Title: Pharmacogenomics of etanercept, infliximab, adalimumab and methotrexate in rheumatoid arthritis. A structured review

Journal Title: Revista Colombiana de Reumatología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rcreue.2018.08.001

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.rcreu.2017.08.004

Content Type: article

Copyright: © 2017 Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U. All rights reserved.